Ac Immune Stock Technical Analysis

ACIU Stock  USD 3.40  0.07  2.02%   
As of the 30th of January, AC Immune owns the Market Risk Adjusted Performance of 0.0897, standard deviation of 5.0, and Coefficient Of Variation of 2618.12. AC Immune technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the entity's future prices.

AC Immune Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as ACIU, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ACIUAC Immune's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

AC Immune Analyst Consensus

Target PriceAdvice# of Analysts
9.37Strong Buy4Odds
AC Immune current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most ACIU analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand ACIU stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of AC Immune, talking to its executives and customers, or listening to ACIU conference calls.
ACIU Analyst Advice Details
Is there potential for Biotechnology market expansion? Will ACIU introduce new products? Factors like these will boost the valuation of AC Immune. If investors know ACIU will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about AC Immune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.94)
Revenue Per Share
0.044
Quarterly Revenue Growth
(0.96)
Return On Assets
(0.22)
Return On Equity
(0.75)
AC Immune's market price often diverges from its book value, the accounting figure shown on ACIU's balance sheet. Smart investors calculate AC Immune's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since AC Immune's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that AC Immune's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AC Immune represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, AC Immune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

AC Immune 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AC Immune's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AC Immune.
0.00
11/01/2025
No Change 0.00  0.0 
In 2 months and 31 days
01/30/2026
0.00
If you would invest  0.00  in AC Immune on November 1, 2025 and sell it all today you would earn a total of 0.00 from holding AC Immune or generate 0.0% return on investment in AC Immune over 90 days. AC Immune is related to or competes with Aldeyra, Cellectis, Alto Neuroscience, Silence Therapeutics, Amarin PLC, Contineum Therapeutics, and Lyell Immunopharma. AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic prod... More

AC Immune Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AC Immune's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AC Immune upside and downside potential and time the market with a certain degree of confidence.

AC Immune Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for AC Immune's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AC Immune's standard deviation. In reality, there are many statistical measures that can use AC Immune historical prices to predict the future AC Immune's volatility.
Hype
Prediction
LowEstimatedHigh
0.173.408.03
Details
Intrinsic
Valuation
LowRealHigh
0.142.747.37
Details
Naive
Forecast
LowNextHigh
0.073.448.06
Details
4 Analysts
Consensus
LowTargetHigh
8.539.3710.40
Details

AC Immune January 30, 2026 Technical Indicators

AC Immune Backtested Returns

AC Immune appears to be very risky, given 3 months investment horizon. AC Immune retains Efficiency (Sharpe Ratio) of 0.0467, which signifies that the company had a 0.0467 % return per unit of price deviation over the last 3 months. We have found twenty-nine technical indicators for AC Immune, which you can use to evaluate the volatility of the entity. Please makes use of AC Immune's Market Risk Adjusted Performance of 0.0897, coefficient of variation of 2618.12, and Standard Deviation of 5.0 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, AC Immune holds a performance score of 3. The firm owns a Beta (Systematic Risk) of 2.27, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, AC Immune will likely underperform. Please check AC Immune's coefficient of variation, semi variance, period momentum indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether AC Immune's current price history will revert.

Auto-correlation

    
  -0.79  

Almost perfect reverse predictability

AC Immune has almost perfect reverse predictability. Overlapping area represents the amount of predictability between AC Immune time series from 1st of November 2025 to 16th of December 2025 and 16th of December 2025 to 30th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AC Immune price movement. The serial correlation of -0.79 indicates that around 79.0% of current AC Immune price fluctuation can be explain by its past prices.
Correlation Coefficient-0.79
Spearman Rank Test-0.53
Residual Average0.0
Price Variance0.05
AC Immune technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of AC Immune technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of AC Immune trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

AC Immune Technical Analysis

Indicator
The output start index for this execution was one with a total number of output elements of sixty. The True Range is a measure of AC Immune volatility developed by Welles Wilder.

About AC Immune Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of AC Immune on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of AC Immune based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on AC Immune price pattern first instead of the macroeconomic environment surrounding AC Immune. By analyzing AC Immune's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of AC Immune's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to AC Immune specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 2025 2026 (projected)
Days Sales Outstanding371.0414.6916.8916.05
PTB Ratio2.222.182.52.38

AC Immune January 30, 2026 Technical Indicators

Most technical analysis of ACIU help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ACIU from various momentum indicators to cycle indicators. When you analyze ACIU charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

AC Immune January 30, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as ACIU stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Additional Tools for ACIU Stock Analysis

When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.